Physician profile
Rene Rubin
NPI 1285633016
$34,373.23
in general payments reported to CMS, 2019-2025
100 companies · $4,666 in 2025
The $4,666 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,597 · 2020: $3,760 · 2021: $4,249 · 2022: $4,970 · 2023: $5,854 · 2024: $4,277 · 2025: $4,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $970 · Long Term Medical Supply Or Device Loan: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,377.89 |
| Education | $969.59 |
| Long Term Medical Supply Or Device Loan | $449.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,497.74 | 2019-2025 | |
| Tesaro, INC. | $3,030.44 | 2019 | |
| Celgene Corporation | $2,164.69 | 2019-2025 | Reblozyl, Pomalyst |
| Bayer Healthcare Pharmaceuticals INC. | $1,983.45 | 2019-2025 | |
| Genzyme Corporation | $1,280.50 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,208.49 | 2019-2025 | Lynparza, Calquence, Enhertu |
| Janssen Biotech, INC. | $1,200.02 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Astellas Pharma US INC | $1,022.10 | 2019-2025 | Xtandi, Vyloy, Xospata |
| E.R. Squibb & Sons, L.L.C. | $997.15 | 2019-2025 | Opdivo, Augtyro, Krazati |
| Seagen INC. | $967.93 | 2019-2025 | Tukysa, Padcev, Adcetris |
| Pfizer INC. | $925.09 | 2019-2025 | |
| Daiichi Sankyo INC. | $774.68 | 2020-2025 | Enhertu, Datroway |
| Emd Serono, INC. | $755.68 | 2019-2024 | Bavencio |
| Amgen INC. | $752.35 | 2019-2023 | Vectibix, Xgeva, Kyprolis |
| Merck Sharp & Dohme LLC | $733.54 | 2019-2025 | Keytruda, Welireg, Lynparza |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $683.77 | 2021-2025 | Botox, Venclexta |
| Incyte Corporation | $579.97 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Exelixis INC. | $541.56 | 2022-2025 | Cabometyx |
| Eisai INC. | $533.48 | 2020-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $514.77 | 2021-2023 | Imbruvica |
| Pharmacosmos Therapeutics INC. | $493.72 | 2021-2025 | Monoferric |
| Glaxosmithkline, LLC. | $439.35 | 2020-2025 | Ojjaara, Jemperli |
| Janssen Scientific Affairs, LLC | $438.49 | 2023-2025 | Erleada |
| Gilead Sciences, INC. | $425.05 | 2021-2025 | Trodelvy |
| Genentech USA, INC. | $403.50 | 2019-2025 | Polivy, Venclexta, Lunsumio |
| Genmab U.S., INC. | $348.77 | 2021-2025 | Epkinly, Tivdak |
| Stemline Therapeutics INC. | $333.99 | 2021-2025 | Orserdu, Elzonris |
| Array Biopharma INC | $326.03 | 2021-2025 | Lorbrena, Braftovi, Mektovi |
| Kite Pharma, INC. | $284.09 | 2021-2025 | Yescarta |
| Sobi, INC | $267.41 | 2022-2025 | |
| Global Blood Therapeutics, INC. | $266.97 | 2020-2022 | |
| Blueprint Medicines Corporation | $264.32 | 2021-2024 | Ayvakit |
| Acrotech Biopharma INC. | $263.69 | 2021-2025 | Beleodaq |
| Tempus Ai, INC | $261.06 | 2024-2025 | Xt Cdx |
| Regeneron Healthcare Solutions, INC. | $237.92 | 2019-2025 | Libtayo |
| Foundation Medicine, INC. | $224.46 | 2019-2021 | |
| Kyowa Kirin, INC. | $211.79 | 2019-2025 | Poteligeo |
| Aveo Pharmaceuticals, INC. | $205.98 | 2021-2025 | Fotivda |
| Alexion Pharmaceuticals, INC. | $189.69 | 2023-2025 | Ultomiris |
| Puma Biotechnology, INC. | $179.38 | 2022-2025 | Nerlynx |
| Sanofi-Aventis U.S. LLC | $175.94 | 2020-2022 | |
| Lilly USA, LLC | $170.90 | 2019-2023 | Verzenio |
| Galvanize Therapeutics, INC | $155.50 | 2025 | Aliya System |
| Takeda Pharmaceuticals U.S.A., INC. | $150.37 | 2023-2025 | Ninlaro, Alunbrig |
| Ferring Pharmaceuticals INC. | $145.99 | 2024 | Adstiladrin |
| Recordati_rare_diseases_inc. | $135.52 | 2023-2025 | Sylvant, Panhematin |
| Fennec Pharmaceuticals, INC. | $132.69 | 2024 | Pedmark |
| Karyopharm Therapeutics INC. | $127.11 | 2023-2025 | Xpovio |
| Jazz Pharmaceuticals INC. | $125.24 | 2020-2025 | |
| Epizyme, INC. | $122.50 | 2020-2022 | |
| Novocure INC. | $115.08 | 2021-2025 | Optune Lua (Novottf-200t) |
| Coherus Oncology, INC. | $114.90 | 2022 | |
| Beigene USA, INC. | $112.49 | 2022-2025 | Brukinsa, Tevimbra |
| Myovant Sciences INC. | $105.23 | 2021 | |
| Alnylam Pharmaceuticals INC. | $102.72 | 2021-2025 | Givlaari |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.93 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $94.67 | 2023-2025 | Avastin, Alymsys |
| Emmaus Medical, INC. | $92.58 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $91.82 | 2022-2025 | Empaveli |
| Rigel Pharmaceuticals, INC. | $89.88 | 2021-2025 | Tavalisse, Rezlidhia, Gavreto |
| Ipsen Biopharmaceuticals, INC | $72.96 | 2022-2024 | Onivyde, Somatuline Depot |
| Cook Medical LLC | $71.72 | 2024 | Cook |
| Mirati Therapeutics, INC. | $70.32 | 2023-2024 | Krazati |
| Acceleron Pharma, INC. | $65.08 | 2021 | |
| Geron Corporation | $63.00 | 2024-2025 | Rytelo |
| US Oncology Corporate, INC. | $61.02 | 2023 | |
| Adc Therapeutics America, INC. | $60.78 | 2022-2025 | |
| Morphosys, US INC. | $59.79 | 2022-2023 | Monjuvi |
| Immunogen, INC. | $55.83 | 2023 | Elahere |
| Beone Medicines USA, INC. | $55.54 | 2025 | Brukinsa |
| Janssen Pharmaceuticals, INC | $53.44 | 2025 | Erleada |
| Invivyd INC | $53.10 | 2025 | Pemgarda |
| Taiho Oncology, INC. | $52.43 | 2019-2022 | |
| Clovis Oncology, INC. | $50.24 | 2020-2021 | |
| Tersera Therapeutics LLC | $49.89 | 2020-2025 | Zoladex |
| Servier Pharmaceuticals LLC | $45.60 | 2024-2025 | |
| Legend Biotech USA INC. | $44.64 | 2025 | Carvykti |
| Pharmaessentia USA Corporation | $44.20 | 2024-2025 | Besremi |
| Adaptive Biotechnologies Corporation | $43.85 | 2023-2024 | Clonoseq |
| Springworks Therapeutics, INC. | $43.61 | 2024-2025 | Ogsiveo |
| Deciphera Pharmaceuticals INC. | $43.31 | 2021-2025 | Romvimza, Qinlock |
| Aurobindo Pharma USA, INC. | $41.01 | 2019 | |
| Dendreon Pharmaceuticals LLC | $40.80 | 2019-2020 | |
| Dova Pharmaceuticals | $39.39 | 2021 | |
| Sun Pharmaceutical Industries INC. | $37.87 | 2020-2021 | |
| Helsinn Therapeutics (U.S.), INC. | $36.09 | 2019 | |
| Iovance Biotherapeutics, INC. | $35.61 | 2025 | Amtagvi |
| G1 Therapeutics, INC. | $35.16 | 2022 | |
| Agios Pharmaceuticals, INC. | $27.96 | 2022-2023 | Pyrukynd |
| Teva Pharmaceuticals USA, INC. | $26.38 | 2019-2020 | |
| Menarini Silicon Biosystems, INC. | $26.14 | 2025 | |
| Octapharma USA, INC. | $24.68 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.98 | 2020 | |
| Azurity Pharmaceuticals, INC. | $23.34 | 2025 | Danziten |
| Fresenius Kabi USA, LLC | $21.92 | 2023 | Stimufend |
| Avyxa Pharma, LLC | $21.46 | 2025 | |
| Secura Bio, INC. | $19.76 | 2024 | Copiktra |
| Antares Pharma, INC. | $17.21 | 2020 | |
| Advanced Accelerator Applications | $17.05 | 2019 | |
| Eusa Pharma (US) LLC | $14.34 | 2019 |
Drugs and devices associated with these payments
Erleada $576Cabometyx $462Keytruda $432Darzalex $405Sarclisa $389Enhertu $389Lenvima $359Tukysa $355Monoferric $328Lynparza $311Welireg $310Trodelvy $270Imbruvica $265Orserdu $262Venclexta $248Monjuvi $239Jakafi $232Epkinly $224Xt Cdx $216Ojjaara $214Lorbrena $204Mektovi $203Braftovi $203Beleodaq $199Kisqali $197Nubeqa $195Xtandi $190Ultomiris $190Reblozyl $184Elahere $183Ayvakit $177Fotivda $175Padcev $164Ibrance $156Aliya System $156Carvykti $154Libtayo $154Adstiladrin $146Tecvayli $142Pluvicto $141Doptelet $141Jevtana $138Rybrevant $138Pedmark $133Xpovio $127Pemazyre $125Opdivo $124Talvey $124Poteligeo $122Xofigo $115Ninlaro $115Elrexfio $114Polivy $113Calquence $111Xalkori $110Sylvant $109Adcetris $98.39Nerlynx $94.78Tivdak $93.15Vitrakvi $89.78Stivarga $89.78Krazati $89.71Bosulif $88.71Comirnaty $88.49Vectibix $87.14Xgeva $87.14Brukinsa $80.94Kyprolis $77.84Piqray $75.75Avastin $73.13Fabhalta $72.35Cook $71.72Imfinzi $70.29Talzenna $69.39Paxlovid $68.39Empaveli $65.89Lunsumio $65.25Columvi $65.25Rytelo $63.00Enjaymo $61.00Vonjo $60.86Nplate $60.13Jemperli $57.30Zepzelca $57.16Scemblix $56.75Datroway $55.43Givlaari $53.41Onivyde $53.30Pemgarda $53.10Vyloy $49.03Promacta $49.02Yescarta $48.11Pomalyst $47.68Tavalisse $47.51Gavreto $47.51Rezlidhia $47.51Zynyz $46.13Besremi $44.20Clonoseq $43.85Ogsiveo $43.61
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.